Granisetron hcl 1 mg oral
Products billed under this code include Granisetron HCl.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under Q0166
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Granisetron HCl | Breckenridge Pharmaceutical, Inc. | 51991-0735-20 | 20 | $15.48 |
| Granisetron HCl | Breckenridge Pharmaceutical, Inc. | 51991-0735-32 | 2 | $1.548 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.774 | – | 1 MG | Granisetron hcl 1 mg oral | v1, posted September 17, 2026 |
| 3Q21 | $1.463 | +$0.319 | 1 MG | Granisetron hcl 1 mg oral | v1, posted June 2, 2022 |
| 2Q21 | $1.144 | −$0.319 | 1 MG | Granisetron hcl 1 mg oral | v1, posted March 1, 2022 |
| 1Q21 | $1.463 | – | 1 MG | Granisetron hcl 1 mg oral | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q21: 2022-06-02_july-2021-asp-pricing-file.zipposted June 2, 2022
- 2Q21: 2022-03-01_april-2021-asp-pricing-file.zipposted March 1, 2022
- 1Q21: 2021-12-10_january-2021-asp-pricing-file.zipposted December 10, 2021